Shareholders and Investors
Third Quarter Business Results for Fiscal Year 2021
Medium-Term Management Plan
Creating New Value Through Innovation in Kampo
Message from the Management
Reports and Downloads
Latest Investor Relations Information
Feb 4, 2022
Announcement of FY2022 3Q Financial Results
Nov 5, 2021
Announcement of FY2022 2Q Financial Results
Aug 5, 2021
Announcement of FY2022 1Q Financial Results
May 11, 2021
Announcement of FY2021 Financial Results
Download the Latest IR Materials
Financials and Business Results
TSUMURA Quality Policy
To contribute to the health of the general public through Kampo (traditional Japanese medicine), we have formulated a quality policy consisting of the following principles.
Learn more about Tsumura’s activities focused on pharmaceutical Kampo products and the current state of Kampo medicine.
Learn more about Kampo.
TSUMURA & CO. received “AA Website” grade in All Japanese Listed Companies' Website Ranking in 2021 by Nikko Investor Relations Co., Ltd.